Gsk PLC GSK
We take great care to ensure that the data presented and summarized in this overview for GSK PLC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GSK
View all-
Boenning & Scattergood, Inc.43.3KShares$1.47 Million0.3% of portfolio
-
Altium Wealth Management LLC33.4KShares$1.14 Million0.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA20KShares$680,7570.06% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL18.6KShares$633,8560.0% of portfolio
-
Loveless Wealth Management LLC15KShares$511,2400.43% of portfolio
-
Crossvault Capital Management LLC9.19KShares$313,0450.16% of portfolio
-
Columbia Asset Management Ann Arbor, MI9.13KShares$310,9670.07% of portfolio
-
Corient Capital Partners, LLC Newport Beach, CA7.97KShares$271,4580.03% of portfolio
-
Minot Wealth Management LLC7.92KShares$269,6180.09% of portfolio
-
Cordasco Financial Network5.21KShares$177,4180.16% of portfolio
Latest Institutional Activity in GSK
Top Purchases
Top Sells
About GSK
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Transactions at GSK
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|